Patton Albertson Miller Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.87M Sell
19,350
-156
-0.8% -$33.6K 0.48% 62
2026
Q1
$4.24M Sell
19,506
-560
-3% -$124K 0.5% 60
2025
Q4
$4.58M Sell
20,066
-573
-3% -$131K 0.54% 61
2025
Q3
$4.78M Buy
20,639
+463
+2% +$94.3K 0.58% 60
2025
Q2
$3.75M Sell
20,176
-182
-0.9% -$33.8K 0.49% 69
2025
Q1
$4.27M Sell
20,358
-739
-4% -$144K 0.63% 54
2024
Q4
$3.75M Sell
21,097
-241
-1% -$44.3K 0.5% 69
2024
Q3
$4.21M Sell
21,338
-117
-0.5% -$21.8K 0.57% 66
2024
Q2
$3.68M Buy
21,455
+85
+0.4% +$14.1K 0.52% 67
2024
Q1
$3.89M Sell
21,370
-750
-3% -$129K 0.58% 64
2023
Q4
$3.43M Sell
22,120
-548
-2% -$79.9K 0.57% 67
2023
Q3
$3.38M Sell
22,668
-554
-2% -$81.3K 0.66% 58
2023
Q2
$3.13M Sell
23,222
-1,870
-7% -$274K 0.6% 61
2023
Q1
$4M Sell
25,092
-1,309
-5% -$200K 0.73% 46
2022
Q4
$4.27M Sell
26,401
-483
-2% -$74.1K 0.78% 43
2022
Q3
$3.61M Sell
26,884
-1,967
-7% -$282K 0.78% 39
2022
Q2
$4.42M Sell
28,851
-2,154
-7% -$329K 0.9% 30
2022
Q1
$5.03M Sell
31,005
-2,365
-7% -$344K 0.86% 30
2021
Q4
$4.52M Buy
33,370
+842
+3% +$99.5K 0.73% 36
2021
Q3
$3.51M Buy
32,528
+6,121
+23% +$699K 0.67% 45
2021
Q2
$2.98M Sell
26,407
-688
-3% -$77.5K 0.68% 55
2021
Q1
$2.93M Sell
27,095
-954
-3% -$102K 0.71% 52
2020
Q4
$2.92M Sell
28,049
-1,567
-5% -$151K 0.69% 47
2020
Q3
$2.59M Sell
29,616
-514
-2% -$48.4K 0.74% 41
2020
Q2
$2.96M Sell
30,130
-73
-0.2% -$6.43K 0.86% 29
2020
Q1
$2.3M Buy
30,203
+76
+0.3% +$6.47K 0.78% 34
2019
Q4
$2.67M Buy
30,127
+236
+0.8% +$19.6K 0.7% 38
2019
Q3
$2.26M Buy
29,891
+2,631
+10% +$180K 0.64% 50
2019
Q2
$1.79M Buy
27,260
+24,203
+792% +$1.9M 0.52% 63
2019
Q1
$246K Sell
3,057
-65
-2% -$5.32K 0.12% 106
2018
Q4
$249K Hold
3,122
0.13% 111
2018
Q3
$248K Hold
3,122
0.13% 114
2018
Q2
$289K Buy
3,122
+373
+14% +$36.4K 0.15% 108
2018
Q1
$260K Sell
2,749
-720
-21% -$79.1K 0.12% 105
2017
Q4
$335K Sell
3,469
-334
-9% -$31.5K 0.14% 106
2017
Q3
$343K Sell
3,803
-7
-0.2% -$533 0.15% 109
2017
Q2
$268K Sell
3,810
-1,131
-23% -$76K 0.12% 116
2017
Q1
$327K Buy
4,941
+516
+12% +$32.4K 0.14% 111
2016
Q4
$277K Sell
4,425
-390
-8% -$23.8K 0.12% 118
2016
Q3
$304K Sell
4,815
-864
-15% -$55.9K 0.13% 115
2016
Q2
$352K Sell
5,679
-2,210
-28% -$135K 0.16% 110
2016
Q1
$451K Sell
7,889
-293
-4% -$16.3K 0.23% 95
2015
Q4
$485K Sell
8,182
-2,360
-22% -$136K 0.24% 93
2015
Q3
$568K Sell
10,542
-3,141
-23% -$204K 0.3% 86
2015
Q2
$919K Sell
13,683
-1,845
-12% -$120K 0.4% 78
2015
Q1
$909K Buy
15,528
+1,695
+12% +$102K 0.37% 82
2014
Q4
$905K Sell
13,833
-1,502
-10% -$94.7K 0.42% 83
2014
Q3
$908K Sell
15,335
-13,904
-48% -$772K 0.47% 83
2014
Q2
$1.66M Sell
29,239
-2,732
-9% -$143K 0.84% 28
2014
Q1
$1.64M Sell
31,971
-4,389
-12% -$222K 0.87% 33
2013
Q4
$1.92M Sell
36,360
-1,042
-3% -$51.2K 1.13% 28
2013
Q3
$1.67M Sell
37,402
-24,143
-39% -$1.07M 0.99% 33
2013
Q2
$2.54M Buy
+61,545
New +$2.69M 1.54% 17

Other funds holding ABBV

Patton Albertson Miller Group's ABBV Position: Q2 2026 in Review

Patton Albertson Miller Group reduced its AbbVie (ABBV) stake by 0.8% in Q2 2026, selling an estimated $33.6K and leaving 19,350 shares worth $4.87M. The position accounts for 0.48% of the portfolio, ranked #62.

Patton Albertson Miller Group first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.03M in Q1 2022. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Patton Albertson Miller Group held 19,350 shares of AbbVie worth $4.87M as of Q2 2026.
  • Patton Albertson Miller Group sold 156 AbbVie shares in Q2 2026, an estimated $33.6K.
  • AbbVie made up 0.48% of Patton Albertson Miller Group's portfolio in Q2 2026, its #62 holding.
  • Patton Albertson Miller Group first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Patton Albertson Miller Group's AbbVie position peaked at $5.03M in Q1 2022.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Patton Albertson Miller Group's 13F filing for Q2 2026, filed 22 Jul 2026.